Catalent | CTLT - Actif À Court Terme



Actif À Court Terme Changement Date
Agilent USD 4.62B 21M 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Bruker USD 2.21B 138.1M 2025-12
Centene USD 40.37B 3.69B 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Cigna USD 47.81B 1.08B 2025-12
Danaher USD 12.76B 3.15B 2025-12
Dentsply International USD 2.02B 49M 2025-12
Elevance Health USD 63B 777M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Glaxosmithkline GBP 23.59B 390.44M 2025-12
Hologic USD 3.84B 175.3M 2025-12
Humana USD 32.73B 19M 2025-12
Illumina USD 3.29B 493M 2025-12
Intuitive Surgical USD 12.4B 927.3M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
J&J USD 55.62B 1.01B 2025-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Lonza CHF 8B 3.41B 2025-12
McKesson USD 59.7B 190M 2025-12
Merck EUR 13.23B 354M 2025-12
Merck USD 47.56B 10.49B 2025-09
Mettler Toledo International USD 1.36B 81.46M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Quest Diagnostics USD 2.38B 29M 2025-12
Repligen USD 1.14B 40.9M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Thermo Fisher Scientific USD 28.71B 6.41B 2025-12
UnitedHealth USD 95.07B 1.37B 2025-09
Veradigm USD 679.65M 131.12M 2022-12
Waters USD 1.99B 69.86M 2025-12
West Pharmaceutical Services USD 1.98B 154.9M 2025-12